Researchers found a correlation between the intensity of a patient's immune response and clinical outcomes in brain cancer patients. The study showed that stronger immune responses were associated with longer survival times and improved treatment outcomes.
A new classification system has been developed to help cardiologists determine the best course of treatment for patients with symptomatic myocardial bridging. The system combines clinical symptoms, non-invasive tests, and heart flow studies to reduce subjective decision-making.
Researchers found that interrupting a signaling pathway in immune system cells opened the possibility of a new strategy against Alzheimer's disease. Immune cells from outside the brain devoured plaque deposits, reducing their numbers by up to 90 percent.
Researchers found that luteolin and diosmin reduced levels of amyloid-beta, a protein that builds up in the brains of patients with Alzheimer's. The flavonoids work by targeting presenilin-1, a protein linked to the disease.
Researchers at Cedars-Sinai Medical Center have developed a novel approach to minimize radiation exposure during coronary CTA, while maintaining diagnostic image quality. The 'Low-dose Coronary CT Angiogram' technique exposes patients to full-dose x-rays for only a fraction of the heart cycle, significantly reducing radiation exposure.
The Cedars-Sinai Heart Institute will feature presentations on various topics related to cardiovascular health, including emerging technologies for heart valve repair and women's heart issues. Researchers will also discuss the link between prohormones and cardiovascular disease risk among post-menopausal women.
Researchers have described the mechanisms by which capon gene variants cause heart rhythm disturbances. The study found that capon interacts with a signaling molecule in heart muscle to influence signaling pathways and modify cell-to-cell interactions, leading to abnormalities in the QT interval of EKGs.
A study in mice suggests that a spectral imaging system could provide immediate results during Hirschsprung's disease surgeries, increasing patient safety and operating room efficiency. This technology identifies diseased tissue based on wavelength, allowing precise localization of interventions.
Researchers developed gene therapy approach that attracts and 'trains' immune system cells to destroy deadly brain cancer cells, promoting long-term immunity and restoring normal brain function. The therapy shows promise as a potential treatment for glioblastoma multiforme, the most common and deadly type of brain cancer.
A new study by the National Institutes of Health found that a stent designed to open clogged brain arteries was successfully deployed in nearly all cases and reduced arterial blockage, but long-term benefits compared to medical treatment alone were inconclusive. A large-scale randomized trial is expected to provide definitive results.
Researchers at Cedars-Sinai Medical Center are conducting a five-year study to test the safety and effectiveness of docosahexanoic acid (DHA) and eicosapentanoic acid (EPA) as treatments for major depressive disorder. The study aims to determine whether these two omega-3 fatty acids can help alleviate symptoms of depression in adults.
Researchers at Cedars-Sinai Medical Center have developed a novel gene delivery system that can sustain therapeutic expression in the central nervous system for up to 1 year. This innovative approach uses an adenoviral vector called HC-Adv, which is invisible to the immune system and renders previously used vectors ineffective.
Gynecomastia, benign enlargement of male breast tissue, affects 40-50% of males at some point in their lives. The condition can be treated with medication or surgery, and awareness is key to correct diagnosis and reassurance for affected men.
A re-analysis of the data used in a controversial meta-analysis suggests that rosiglitazone's cardiovascular risks may not be as high as initially reported. The study finds that only prospective clinical trials can definitively establish the drug's safety.
The EASE Trial investigates an experimental procedure called airway bypass designed to create pathways in the lung for trapped air to escape, potentially relieving shortness of breath and other symptoms. The study aims to improve lung function and quality of life for emphysema patients.
Cedars-Sinai researchers presented innovative insights into the pituitary gland's link to systemic illness, mental disorders, and aging. They also showcased advancements in subcellular mechanisms and treatment outcomes for patients with acromegaly, a growth hormone disorder.
Researchers at Cedars-Sinai are studying a gene that may play a role in the development of polycystic ovary syndrome (PCOS), a condition characterized by insulin resistance, hirsutism, and other symptoms. The study aims to better understand the molecular mechanisms underlying PCOS and potential markers for risk.
A new class of targeted cancer drugs, pertuzumab, shows promise in slowing the progression of recurrent prostate cancer. The study found that prolonged median survival time was achieved by 16.4 months with the drug compared to 10.7 months in a historical control group.
Researchers at Cedars-Sinai Medical Center successfully cultured stem cells from human bone marrow that can differentiate into neurons and other central nervous system cells. These cells exhibit behaviors similar to those derived from brain tissue, suggesting a promising approach for treating brain disorders and tumors.
A new study reveals that women who outwardly express anger may be at increased risk of heart disease if they also have certain risk factors such as diabetes, unhealthy levels of fats in the blood, or age. The researchers found that only expressed anger, not just cynicism or hostility, was predictive of coronary artery disease in women.
Acromegaly, a condition caused by pituitary gland disorders, has seen improvements in diagnosis and treatment due to advances in medical technology and medication. Effective control of the disorder is now possible for many patients, reducing negative implications such as tissue damage and hormone imbalance.
Researchers at Cedars-Sinai Medical Center identified genes that make brain cancer-causing stem cells resistant to chemotherapy and other treatments. The study found that these cells can regenerate and become even more aggressive after treatment, highlighting a potential target for new therapies.
The study identified two genes linked to Crohn's disease: Nod2 and IL-23R. This discovery may lead to improved diagnosis and targeted drug therapies for patients with Crohn's disease.
Researchers at Cedars-Sinai Medical Center found that a nonabsorbable antibiotic can effectively treat irritable bowel syndrome (IBS) even after treatment ends. The study showed sustained benefits for participants who received rifaximin, providing new hope for those suffering from IBS.
Researchers developed a gene transfer method using the mutant form of apolipoprotein A-I (Apo A-I Milano) to treat vascular inflammation and plaque buildup. The study found that Apo A-I Milano gene transfer resulted in a 65% reduction in plaque buildup, compared to a 25% decrease with the normal HDL gene.
Researchers have combined two therapies to enhance the immune system's response against brain tumors. The treatment, called dendritic cell-interleukin-23, promotes the function of dendritic cells and memory T-cells, providing initial and long-term immunity.
A study published in Circulation found that the financial burden on women with chest pain and blocked coronary arteries can total more than $1 million during their lifetime. Women with nonobstructive coronary artery disease also face significant costs, including higher drug expenses.
A new study from Cedars-Sinai Medical Center found that obesity can affect the progression and outcome of ovarian cancer, with obese women experiencing shorter survival times and earlier death. The study suggests that excess fat may be excreting a hormone or protein that causes ovarian cancer cells to grow more aggressively.
Researchers at Cedars-Sinai Medical Center developed new objective criteria to enhance the reliability of PET scans in detecting breast cancer metastasis. The criteria use a standardized uptake value (SUV) threshold of 2.3, which was found to accurately diagnose lymph node involvement with 100% specificity and positive predictive value.
This study confirms the existence of immunological synapses, microanatomical structures similar to those of nerve cells, in laboratory rats. The findings settle controversy over their existence and functional significance during antiviral immune responses, paving the way for further research.
A large-scale study found that adding a broad-spectrum psychotropic agent, Risperidone, to standard antidepressant therapy can effectively treat resistant major depressive disorder. Patients who were less severely ill only needed a brief period of Risperidone treatment to experience lasting benefits.
Researchers have developed a new approach to treating gliomas, deadly brain tumors, by delivering radioactive iodine using a man-made version of scorpion venom as a carrier. The treatment targets glioma cells without affecting neighboring tissue or body organs and has shown promise in Phase I clinical trials.
Research suggests that phosphodiesterase-5 inhibitors (PDE-5i) have mostly positive effects on various organ systems, including the blood, heart, lungs, and brain. The drugs are effective in treating erectile dysfunction even for men with diabetes, high blood pressure, and ischemic heart disease.
The Pauletta and Denzel Washington Family Gifted Scholars Program in Neuroscience awards $2,500 monthly support to graduate researchers and $2,000 per month to undergraduate students. The program aims to train the next generation of life scientists and promote significant contributions in the sciences.
Researchers investigated TLR5 gene variants and their relationship to Crohn's Disease, finding effects on both Jews and non-Jews. The study highlights the importance of considering ethnicity in future investigations for better therapies.
Researchers at Cedars-Sinai Medical Center have developed a novel gene therapy strategy that modifies the brain microenvironment to induce an effective immune response against deadly brain tumors and infections. The treatment uses Flt3 Ligand to recruit antigen-presenting cells, which can destroy tumors and combat brain infections.
Researchers at Cedars-Sinai Medical Center have identified the potential benefits of Raloxifene in treating advanced prostate cancer. The study showed that Raloxifene can slow or stop the growth of prostate cancer, offering new hope for patients with androgen-independent disease.
Researchers found that marrow-derived neural stem-like cells genetically engineered to produce interleukin-23 can track and destroy glioma cells, providing long-term immunity. This discovery offers a promising new therapeutic option for treating brain tumors.
Researchers identify KCNC3 mutations as causative factors in neurodegenerative diseases, providing a new perspective on the role of potassium channels in human neurodegeneration. The study's findings have significant implications for the development of therapeutic targets and treatment strategies for brain disorders.
A study at Cedars-Sinai Medical Center found that angioplasty with drug-eluting stents resulted in outcomes equivalent to bypass surgery for patients with left main coronary artery disease. The treatment was shown to have similar short- and intermediate-term clinical outcomes, despite higher risk patient demographics.
Research finds that women's heart disease has distinct characteristics, including cellular and microvascular dysfunction. The study highlights the importance of considering gender-specific risk factors and diagnostic tools to improve detection and treatment.
Cedars-Sinai researchers discovered a biochemical pathway that makes gliomas and other cancer cells more sensitive to TRAIL, a protein inducing apoptosis in cancer cells. By combining TRAIL with pioglitazone, a diabetes drug, they aim to enhance the effectiveness of therapies targeting cancer cells.
Cedars-Sinai researchers have developed a new delivery system that can effectively regulate therapeutic gene expression, overcoming obstacles in bringing genetic therapies to humans. The system allows for the flexibility to turn gene expression on or off, even in the presence of an immune response, making it a critical tool for treatin...
A new study suggests that video-assisted thoracoscopic surgery can be a viable option for older patients with early-stage non-small cell lung cancer. The procedure has been shown to have low risk and good success rates, allowing patients to avoid the consequences of widespread cancer.
A new study published in Catheterization and Cardiovascular Interventions found that drug-eluting stents reduce the incidence of restenosis, heart attacks, and death by fourfold compared to conventional stents. Medicated stents were effective in keeping vein grafts open without affecting other parts of the bypass.
Researchers have developed a novel approach to prevent and treat atherosclerosis by transferring the apo A-I Milano gene or using antibody therapy to reduce plaque buildup. The studies show that these methods can significantly shrink existing plaques and even remove bad cholesterol.
A recent study published at the American College of Gastroenterology's annual meeting found that targeted antibiotics, specifically rifaximin, resulted in a significant and long-lasting improvement in IBS symptoms. Patients who received the antibiotic experienced a 37% overall improvement in their symptoms, compared to 23% on placebo.
Researchers at Cedars-Sinai Medical Center found that shortness of breath can signify a higher risk of dying from cardiac disease. The study, which evaluated nearly 18,000 patients, revealed that patients with shortness of breath were four times more likely to suffer death from a cardiac cause than asymptomatic patients.
Researchers discovered a specific endometrial target gene, GlcNAc-6-OST, plays a crucial role in the implantation process. Increasing estrogen and progesterone levels enhances this gene's expression, facilitating L-selectin ligand production and successful implantation.
Researchers developed a large brain tumor model and tested a genetically engineered virus delivering two proteins to the brain. The findings show that combined RAdTK and RAdFlt3L gene therapy eliminated glioblastoma multiforme in lab rats, increasing survival rates significantly.